Treating fatty liver and insulin resistance
Aging (Albany NY)
.
2013 Nov;5(11):791-2.
doi: 10.18632/aging.100617.
Authors
Rachel J Perry
1
,
Gerald I Shulman
Affiliation
1
Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06519, USA;
PMID:
24304662
PMCID:
PMC3868721
DOI:
10.18632/aging.100617
No abstract available
Publication types
Editorial
MeSH terms
2,4-Dinitrophenol / analogs & derivatives*
2,4-Dinitrophenol / therapeutic use*
Animals
Fatty Liver / drug therapy*
Insulin Resistance*
Substances
2,4-dinitrophenol methyl ether
2,4-Dinitrophenol
Grants and funding
P30 DK045735/DK/NIDDK NIH HHS/United States
R01 DK049230/DK/NIDDK NIH HHS/United States
U24 DK059635/DK/NIDDK NIH HHS/United States